Your Health. Your Family. Your Choice.
Administered by: Unknown Purchased by: Unknown
Life Threatening? No
Write-up: Case received from the Health Authorities on 31-JUL-2009 under the reference numbers MA20091226 and 09-2228. Information has been received from an agency concerning a 14-year-old female patient who had been followed within a child in psychiatry environment from the age of 18 months to 12 years old received the first dose of GARDASIL (batch number not reported) via intramuscular route at the level of the left upper limb on 09-NOV-2008. One month later, she developed pain starting in the left upper limb, at the level of the scapular belt, then reaching the left leg, followed by right arm and then the right leg. After a consultation she was hospitalized from 27-JAN-2009 to 30-JAN-2009 at the Child Neurology Unit. The following work-up were performed and were normal: standard x-ray examination, left shoulder echotomography, shoulder MRI, cerebral MRI, 4 limbs electromyography, electroencephalography. Troponin, C-Reactive Protein, creatine kinase, lactic dehydrogenase, anti-Sm and anti-RNP antibodies, anti-SSA/Ro and anti-SSB/La antibodies, immunoglobulins M and immunoglobulins G were normal. Only the immunoglobulins A were a little high at 2.78. These pains, accompanied with sensitivity disorders, evoked a Parsonage-Turner syndrome but it was ruled out due to the resistance to corticotherapy. Final diagnosis was "rebel pain with a functional component". The teenager was treated with LAROXYL, EFFERALGAN CODEINE and MYOLASTAN following to a consultation to a pain center. At the time of report, the patient had not yet recovered. Sensory disturbance and pain in the joint involving the shoulder region, lower leg and limb were considered to be disabling. Other business partner numbers included E2009-07668.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166